Travere Therapeutics, Inc. · NASDAQ:TVTX
Rock Springs Capital Management LP reported a 5.72% stake in Travere Therapeutics, Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 14, 2025
Rock Springs Capital Management LP reported a 5.72% stake in Travere Therapeutics, Inc., 4,973,649 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).
- Stake
- 5.72%
- Shares
- 4,973,649
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Rock Springs Capital Management LP | 5.72% | 4,973,649 |
| Rock Springs Capital LLC | 5.72% | 4,973,649 |
| Rock Springs Capital Master Fund LP | 4.81% | 4,180,000 |
| Mark Bussard | 5.72% | 4,973,649 |
| Kris Jenner | 5.72% | 4,973,649 |
Source
Related
- Travere Therapeutics, Inc.
- Rock Springs Capital Management LP
- Travere Therapeutics, Inc. shareholders
- Schedule 13G/A · Rock Springs Capital Management LP · May 15, 2025
- Form 4 · Dube Eric M · Oct 19, 2026
- Form 4 · Heerma Peter · Sep 17, 2026
- Form 4 · Dube Eric M · Sep 17, 2026
- Form 4 · Rote William E. · Sep 17, 2026
- Form 4 · Inrig Jula · Sep 17, 2026